Clinical Trial

An Observational Study of Patients With Chronic Liver Disease

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2023-02-15; most recent amendment 2026-03-02.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-10-17
Trial Details
NCT Number NCT05744713
Lead Sponsor Target PharmaSolutions, Inc.
Conditions Chronic Liver Disease, Cirrhosis
Enrollment 500,000 participants
Start Date 2024-02-19
Primary Completion 2037-12-31 (estimated)
Study Completion 2037-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-03